Feedback

X
Immunotherapy in Hepatocellular Carcinoma

Immunotherapy in Hepatocellular Carcinoma

0 Ungluers have Faved this Work
Based on this evidence, a deep understanding of the immunological status and biological targets modulating immunological microenvironments should be quite informative for the development of future immunotherapy in HCC. From this point of view, this Special Issue will highlight the current state of the art in the immunotherapy of HCC from both the basic and clinical perspectives, and outline future perspectives for improving therapies.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 20 times via unglue.it ebook links.
  1. 20 - pdf (CC BY) at Unglue.it.

Keywords

  • a disintegrin and metalloprotease 9
  • alpha fetoprotein response
  • anti-VEGF inhibitor
  • biomarkers
  • cancer immunotherapy
  • CD14+ cells
  • check-point inhibitors
  • Clinical & internal medicine
  • combination immunotherapy
  • combination therapies
  • combination therapy
  • copy number variations
  • CTLA-4
  • Diseases & disorders
  • effectiveness
  • genetic alteration
  • HCC
  • hepatocellular carcinoma
  • hepatocellular carcinoma (HCC)
  • immune checkpoint blockade
  • immune checkpoint inhibition
  • immune checkpoint inhibitor
  • immune phenotype
  • immune-related adverse events (irAEs)
  • Immunotherapy
  • liver cancer
  • Liver disease
  • medicine
  • MicroRNAs
  • Molecular classification
  • molecular-targeted agent
  • Mutations
  • natural killer
  • Nivolumab
  • oncogenic signal
  • oncology
  • outcome
  • PD-1
  • PD-1 antibody
  • PD-L1
  • PD-L1 antibody
  • predictive factors
  • Predictive markers
  • programmed death 1 ligands
  • Safety
  • stem cell marker
  • TACE
  • TCGA
  • therapy resistance
  • tissue-resident memory CD8 T cells
  • translational approaches
  • Tyrosine Kinase Inhibitor
  • unresectable hepatocellular carcinoma
  • β-catenin

Links

DOI: 10.3390/books978-3-0365-6690-0

Editions

edition cover

Share

Copy/paste this into your site: